FDA Releases The Guidance Document for ALS

09/23/2019 – Thanks in part to certain outspoken ALS sufferers (namely: Matt Bellina) and more importantly all of you – the ALS community supporters –  the FDA listened, acted and published the: GUIDANCE DOCUMENT – Amyotrophic Lateral Sclerosis: Developing Drugs for Treatment Guidance for Industry.

Your help does make a difference, our first goal has been accomplished.

Visit the FDA page LINK CLICK HERE

Our collective voice can make a difference. Thank you for your support. Let’s keep the momentum going and achieve our next goal: to get an executive order signed that will allow for full approval of NurOwn®.